$ORCL

VA seeks to extend its Oracle health record contract through 2031

The U.S. Department of Veterans Affairs is seeking to extend its Oracle Health contract for electronic health record modernization by three additional one-year optional ordering periods, potentially through May 16, 2031, according to a SAM.gov notice. VA’s current deal expires May 2028. The notice cites continued deployment and support needs; the contract ceiling increase to $9.996B is redacted.

Original reporting
Published Aug 13, 2026, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 7:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
VA seeks to extend its Oracle health record contract through 2031 — source image
Decision brief

The 30-second read

$ORCLBullishMed
01

Why it matters

The proposed modification would extend the period of performance and increase the contract ceiling (amount redacted), supporting continued EHR deployment and support until all VA facilities transition.

02

Market read

A federal EHR contract extension through 2031 is a tangible procurement update for Oracle’s government health IT business, with execution risk still highlighted by prior safety issues.

03

What to watch

VA’s history of safety and usability issues, plus the prior renegotiation in May 2023, implies continued execution risk that could affect future renewals or scope changes.

Relevance 7/10Novelty 7/10Timing: SAM.gov notice published Tuesday, ahead of VA’s next EHR deployment milestones in 2026.

Background

VA originally contracted with Cerner in 2018; Oracle acquired Cerner in 2022 and rebranded the unit as Oracle Health.

Company-level read

Ticker impact

$ORCLBullishMedium confidence
Context

VA seeks to extend its Oracle Health Government Services EHR contract by three additional one-year optional ordering periods through May 16, 2031.

Expected impact

Modestly positive for ORCL expectations, but likely limited near-term impact given contract value details are redacted.

Evidence & confidence

The notice is a concrete contract modification request/extension, but the article does not disclose the final incremental dollar amount (redacted), limiting precision on financial impact.

Market effects

Reinforces demand for large-scale federal EHR modernization and ongoing support obligations for major health IT vendors.

Primarily US federal healthcare IT procurement, with operational focus on VA medical facilities.

Limited direct global read-through, but supports the broader government health IT modernization theme.

Counterpoint

Because the contract ceiling increase and new total are redacted, the incremental financial upside for Oracle may be smaller than headline framing suggests.

Key entities

  • Department of Veterans Affairs

    Seeking to extend its EHR modernization contract with Oracle Health Government Services.

  • Oracle Health Government Services, Inc.

    Sole-source provider named in the SAM.gov notice for the firm-fixed-price contract modification.

  • Oracle

    Subject of the contract extension request via its Oracle Health Government Services unit.

Related articles

$ORCLHighAI 9/10

VA Adds Nearly $17B to Its Oracle EHR Overhaul

The VA expanded its Oracle EHR contract by $17B, raising the total to $27B. The funds will support deployment through 2031 across 164 medical facilities. The increase follows delays and usability issues, with the VA citing the need to avoid running out of funds. The project aims to align VA and Defense Department records.

$ORCLMed

Why is Oracle stock rising today?

Oracle (ORCL) stock rose 2.0% to $157.13 on analyst upgrades and pre-earnings optimism. Morgan Stanley raised its target to $210, Bernstein reiterated Outperform, and Jefferies kept Buy but lowered target to $290. Oracle reports Q1 FY2027 results on September 10, 2026. Broader market is mixed, with S&P 500 down 0.1% and Nasdaq slightly positive.

$ORCLMedAI 8/10

Oracle Stock Is Off 59% From Its High. Why This Could Be the Best Time to Buy.

Oracle (ORCL) stock is down 59% from its high, but the company reports strong customer contracts and expects earnings growth. It anticipates adjusted EPS of $1.72-$1.76 for Q1, with revenue and earnings growth accelerating in the second half of fiscal 2027. Long-term, Oracle projects 31% and 28% annual revenue and earnings growth, respectively, through 2030. Analysts rate it a 'Strong Buy'.

$ORCLMed

Oracle Stock Surges 5.7% Against Market Trend: A Dual Play Between Fed Dovish Signals and AI Infrastructure Heavy Burdens

Oracle (ORCL) rose 5.7% on September 3, driven by Fed comments suggesting a potential pause in rate hikes. The company's heavy debt burden makes it sensitive to interest rates. Oracle's stock has fallen 55% from its peak, but revenue grew 17% and cloud infrastructure revenue increased 75% in fiscal 2026. The company's valuation has become more attractive, with a forward P/E of 17.

$ORCLMed

Oracle expands AWS partnership, adds quantum computing deal

Oracle and AWS expanded their partnership, launching Oracle Exadata Database Service on AWS and adding quantum computing capabilities via a deal with Quantinuum. Oracle's stock rose 0.31% to $153.76. The service is now available in 22 AWS regions, and Oracle announced new AI applications for HR and healthcare. Oracle's next earnings report is expected on September 8, 2026, with projected EPS of $1.67 and revenue of $19.13 billion.